mRNA Vaccine and Therapeutics Market By Product (Prophylactic Vaccines, Therapeutic Vaccines, Therapeutic Drugs, and Others), Disease Type (Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1, Hereditary Transthyretin-mediated Amyloidosis Genetic, Atherosclerotic Cardiovascular Disease, Others), Treatment Type (Monoclonal Antibody, Gene Therapy, Cell Therapy, and Others), Route of Delivery (Intradermal, Subcutaneous, Intramuscular, Intravenous, and Intranodal), Application (Rare Genetic Diseases, Oncology, Respiratory Diseases, Infectious Diseases, and Others), End-use (Hospitals & Clinics, Research Laboratories & Organizations, and Others), and Region - Market Perspective, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecast for 2023 – 2030

Chapter 1. Executive Summary

Chapter 2. Research Methodology

2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary sources
2.3.1.1. Preliminary data mining
2.3.2. Primary sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook

3.1. Introduction
3.2. Key trends
3.2.1. Soaring Demand for New Vaccines and Therapeutics Drives the Market Growth
3.3. Market drivers
3.3.1. Growing Research on mRNA Vaccines Propels the Market Growth
3.4. Market restraints
3.4.1. High Cost Associated with mRNA-based Vaccines and Therapeutics Hampers the Market Growth
3.5. Market opportunities
3.5.1. Rapid Innovation and Application of Cloud Based Solutions Provides Lucrative Opportunities for the Growth of the Market
3.6. Market Challenges
3.6.1. Strict Legal Regulatory Approval and Potential Side Effects Pose a Challenge for the Market
3.7. Porter’s Five Forces Analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis

Chapter 4. COVID-19 Impact on Global MRNA Vaccine and Therapeutics Market

Chapter 5. Global MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)

5.1. Global MRNA Vaccine and Therapeutics Market Share, By Product, 2018 - 2032 (USD Million)
5.1.1. Prophylactic Vaccines
5.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.2. Therapeutic Vaccines
5.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.3. Therapeutic Drugs
5.1.3.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
5.1.4. Others
5.1.4.1. Market Size and Projections, 2018 - 2032 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 6. Global MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)

6.1. Global MRNA Vaccine and Therapeutics Market Share, By Disease Type, 2018 - 2032 (USD Million)
6.1.1. Acute Hepatic Porphyria
6.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
6.1.2. Primary Hyperoxaluria Type 1
6.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
6.1.3. Hereditary Transthyretin-mediated Amyloidosis Genetic
6.1.3.1. Market Size and Projections, 2018 - 2032 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
6.1.4. Atherosclerotic Cardiovascular Disease
6.1.4.1. Market Size and Projections, 2018 - 2032 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
6.1.5. Others
6.1.5.1. Market Size and Projections, 2018 - 2032 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 7. Global MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)

7.1. Global MRNA Vaccine and Therapeutics Market Share, By Treatment Type, 2018 - 2032 (USD Million)
7.1.1. Monoclonal Antibody
7.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
7.1.2. Gene Therapy
7.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
7.1.3. Cell Therapy
7.1.3.1. Market Size and Projections, 2018 - 2032 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
7.1.4. Others
7.1.4.1. Market Size and Projections, 2018 - 2032 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 8. Global MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)

8.1. Global MRNA Vaccine and Therapeutics Market Share, By Route of Delivery, 2018 - 2032 (USD Million)
8.1.1. Intradermal
8.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
8.1.2. Subcutaneous
8.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
8.1.3. Intramuscular
8.1.3.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.3.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
8.1.4. Intravenous
8.1.4.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.4.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
8.1.5. Intranodal
8.1.5.1. Market Size and Projections, 2018 - 2032 (USD Million)
8.1.5.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 9. Global MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)

9.1. Global MRNA Vaccine and Therapeutics Market Share, By Application, 2018 - 2032 (USD Million)
9.1.1. Rare Genetic Diseases
9.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
9.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
9.1.2. Oncology
9.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
9.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
9.1.3. Respiratory Diseases
9.1.3.1. Market Size and Projections, 2018 - 2032 (USD Million)
9.1.3.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
9.1.4. Infectious Diseases
9.1.4.1. Market Size and Projections, 2018 - 2032 (USD Million)
9.1.4.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
9.1.5. Others
9.1.5.1. Market Size and Projections, 2018 - 2032 (USD Million)
9.1.5.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 10. Global MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)

10.1. Global MRNA Vaccine and Therapeutics Market Share, By End-use, 2018 - 2032 (USD Million)
10.1.1. Hospitals & Clinics
10.1.1.1. Market Size and Projections, 2018 - 2032 (USD Million)
10.1.1.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
10.1.2. Research Laboratories & Organizations
10.1.2.1. Market Size and Projections, 2018 - 2032 (USD Million)
10.1.2.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)
10.1.3. Others
10.1.3.1. Market Size and Projections, 2018 - 2032 (USD Million)
10.1.3.2. Market Size and Projections, by Region, 2018 - 2032 (USD Million)

Chapter 11. Global MRNA Vaccine and Therapeutics Market Overview, By Geography, 2018 - 2032 (USD Million)

11.1. Global MRNA Vaccine and Therapeutics Market Share, By Geography, 2018 - 2032 (USD Million)
11.1.1. Market size and projections, by Countries, 2018 - 2032 (USD Million)
11.1.2. Market Share and CAGR Comparison, by Countries, 2022 - 2032 (%)

Chapter 12. North America MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)

12.1. North America MRNA Vaccine and Therapeutics Market Overview, 2018 - 2032 (USD Million)
12.1.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.2. North America MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.3. North America MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
12.1.4. North America MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
12.1.5. North America MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
12.1.6. North America MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.7. North America MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
12.1.8. North America MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)
12.1.8.1. U.S. MRNA Vaccine and Therapeutics Market Overview, 2018 - 2032 (USD Million)
12.1.8.1.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.8.1.2. U.S. MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.8.1.3. U.S. MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
12.1.8.1.4. U.S. MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
12.1.8.1.5. U.S. MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
12.1.8.1.6. U.S. MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.8.1.7. U.S. MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
12.1.8.2. Canada MRNA Vaccine and Therapeutics Market Overview, 2018 - 2032 (USD Million)
12.1.8.2.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.8.2.2. Canada MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.8.2.3. Canada MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
12.1.8.2.4. Canada MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
12.1.8.2.5. Canada MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
12.1.8.2.6. Canada MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.8.2.7. Canada MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
12.1.8.3. Mexico MRNA Vaccine and Therapeutics Market Overview, 2018 - 2032 (USD Million)
12.1.8.3.1. Market Size and projections, 2018 - 2032 (USD Million)
12.1.8.3.2. Mexico MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
12.1.8.3.3. Mexico MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
12.1.8.3.4. Mexico MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
12.1.8.3.5. Mexico MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
12.1.8.3.6. Mexico MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
12.1.8.3.7. Mexico MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)

Chapter 13. Europe MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)

13.1. Europe MRNA Vaccine and Therapeutics Market Overview, 2018 - 2032 (USD Million)
13.1.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.2. Europe MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.3. Europe MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
13.1.4. Europe MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
13.1.5. Europe MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
13.1.6. Europe MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.7. Europe MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
13.1.8. Europe MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)
13.1.8.1. Germany
13.1.8.1.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.8.1.2. Germany MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.8.1.3. Germany MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
13.1.8.1.4. Germany MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
13.1.8.1.5. Germany MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
13.1.8.1.6. Germany MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.8.1.7. Germany MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
13.1.8.2. France
13.1.8.2.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.8.2.2. France MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.8.2.3. France MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
13.1.8.2.4. France MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
13.1.8.2.5. France MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
13.1.8.2.6. France MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.8.2.7. France MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
13.1.8.3. UK
13.1.8.3.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.8.3.2. UK MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.8.3.3. UK MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
13.1.8.3.4. UK MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
13.1.8.3.5. UK MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
13.1.8.3.6. UK MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.8.3.7. UK MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
13.1.8.4. Italy
13.1.8.4.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.8.4.2. Italy MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.8.4.3. Italy MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
13.1.8.4.4. Italy MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
13.1.8.4.5. Italy MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
13.1.8.4.6. Italy MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.8.4.7. Italy MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
13.1.8.5. Spain
13.1.8.5.1. Market Size and projections, 2018 - 2032 (USD Million)
13.1.8.5.2. Spain MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.8.5.3. Spain MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
13.1.8.5.4. Spain MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
13.1.8.5.5. Spain MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
13.1.8.5.6. Spain MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.8.5.7. Spain MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
13.1.8.6. Rest of Europe
13.1.8.6.1. Market Size and projections, 2018 - 2032
13.1.8.6.2. Rest of Europe MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
13.1.8.6.3. Rest of Europe MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
13.1.8.6.4. Rest of Europe MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
13.1.8.6.5. Rest of Europe MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
13.1.8.6.6. Rest of Europe MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
13.1.8.6.7. Rest of Europe MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)

Chapter 14. Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)

14.1. Asia Pacific MRNA Vaccine and Therapeutics Market Overview, 2018 - 2032 (USD Million)
14.1.1. Market Size and projections, 2018 - 2032 (USD Million)
14.1.2. Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.3. Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
14.1.4. Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
14.1.5. Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
14.1.6. Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
14.1.7. Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
14.1.8. Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)
14.1.8.1. India
14.1.8.1.1. Market Size and projections, 2018 - 2032 (USD Million)
14.1.8.1.2. India MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.8.1.3. India MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
14.1.8.1.4. India MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
14.1.8.1.5. India MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
14.1.8.1.6. India MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
14.1.8.1.7. India MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
14.1.8.2. China
14.1.8.2.1. Market Size and projections, 2018 - 2032 (USD Million)
14.1.8.2.2. China MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.8.2.3. China MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
14.1.8.2.4. China MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
14.1.8.2.5. China MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
14.1.8.2.6. China MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
14.1.8.2.7. China MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
14.1.8.3. Japan
14.1.8.3.1. Market Size and projections, 2018 - 2032 (USD Million)
14.1.8.3.2. Japan MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.8.3.3. Japan MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
14.1.8.3.4. Japan MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
14.1.8.3.5. Japan MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
14.1.8.3.6. Japan MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
14.1.8.3.7. Japan MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
14.1.8.4. South Korea
14.1.8.4.1. Market Size and projections, 2018 - 2032 (USD Million)
14.1.8.4.2. South Korea MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.8.4.3. South Korea MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
14.1.8.4.4. South Korea MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
14.1.8.4.5. South Korea MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
14.1.8.4.6. South Korea MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
14.1.8.4.7. South Korea MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
14.1.8.5. Rest of Asia Pacific
14.1.8.5.1. Market Size and projections, 2018 - 2032 (USD Million)
14.1.8.5.2. Rest of Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
14.1.8.5.3. Rest of Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
14.1.8.5.4. Rest of Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
14.1.8.5.5. Rest of Asia Pacific MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
14.1.8.5.6. Rest of Asia Pacific MRNA Vaccine and Therapeutics Market Overview, Application, 2018 - 2032 (USD Million)
14.1.8.5.7. Rest of Asia Pacific MRNA Vaccine and Therapeutics Market Overview, End-use, 2018 - 2032 (USD Million)

Chapter 15. Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)

15.1. Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, 2018 - 2032 (USD Million)
15.1.1. Market Size and projections, 2018 - 2032 (USD Million)
15.1.2. Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
15.1.3. Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
15.1.4. Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
15.1.5. Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
15.1.6. Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
15.1.7. Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
15.1.8. Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)
15.1.8.1. GCC
15.1.8.1.1. Market Size and projections, 2018 - 2032 (USD Million)
15.1.8.1.2. GCC MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
15.1.8.1.3. GCC MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
15.1.8.1.4. GCC MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
15.1.8.1.5. GCC MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
15.1.8.1.6. GCC MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
15.1.8.1.7. GCC MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
15.1.8.2. South Africa
15.1.8.2.1. Market Size and projections, 2018 - 2032 (USD Million)
15.1.8.2.2. South Africa MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
15.1.8.2.3. South Africa MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
15.1.8.2.4. South Africa MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
15.1.8.2.5. South Africa MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
15.1.8.2.6. South Africa MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
15.1.8.2.7. South Africa MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
15.1.8.3. Rest of Middle East & Africa
15.1.8.3.1. Market Size and projections, 2018 - 2032 (USD Million)
15.1.8.3.2. Rest of Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
15.1.8.3.3. Rest of Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
15.1.8.3.4. Rest of Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
15.1.8.3.5. Rest of Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
15.1.8.3.6. Rest of Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
15.1.8.3.7. Rest of Middle East & Africa MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)

Chapter 16. South America MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)

16.1. South America MRNA Vaccine and Therapeutics Market Overview, 2018 - 2032 (USD Million)
16.1.1. Market Size and projections, 2018 - 2032 (USD Million)
16.1.2. South America MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
16.1.3. South America MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
16.1.4. South America MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
16.1.5. South America MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
16.1.6. South America MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
16.1.7. South America MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
16.1.8. South America MRNA Vaccine and Therapeutics Market Overview, By Countries, 2018 - 2032 (USD Million)
16.1.9. Brazil
16.1.9.1. Market Size and projections, 2018 - 2032 (USD Million)
16.1.9.2. Brazil MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
16.1.9.3. Brazil MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
16.1.9.4. Brazil MRNA Vaccine and Therapeutics Market Overview, By Treatment TypeProduct, 2018 - 2032 (USD Million)
16.1.9.5. Brazil MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
16.1.9.6. Brazil MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
16.1.9.7. Brazil MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
16.1.10. Argentina
16.1.10.1. Market Size and projections, 2018 - 2032 (USD Million)
16.1.10.2. Argentina MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
16.1.10.3. Argentina MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
16.1.10.4. Argentina MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
16.1.10.5. Argentina MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
16.1.10.6. Argentina MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
16.1.10.7. Argentina MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)
16.1.11. Rest of South America
16.1.11.1. Market Size and projections, 2018 - 2032
16.1.11.2. Rest of South America MRNA Vaccine and Therapeutics Market Overview, By Product, 2018 - 2032 (USD Million)
16.1.11.3. Rest of South America MRNA Vaccine and Therapeutics Market Overview, By Disease Type, 2018 - 2032 (USD Million)
16.1.11.4. Rest of South America MRNA Vaccine and Therapeutics Market Overview, By Treatment Type, 2018 - 2032 (USD Million)
16.1.11.5. Rest of South America MRNA Vaccine and Therapeutics Market Overview, By Route of Delivery, 2018 - 2032 (USD Million)
16.1.11.6. Rest of South America MRNA Vaccine and Therapeutics Market Overview, By Application, 2018 - 2032 (USD Million)
16.1.11.7. Rest of South America MRNA Vaccine and Therapeutics Market Overview, By End-use, 2018 - 2032 (USD Million)

Chapter 17. Competitive Landscape

17.1. Competitive environment, 2022
17.2. Strategic framework
17.2.1. Partnership/agreement
17.2.2. Expansion
17.2.3. Mergers & Acquisitions
17.2.4. Recent development

Chapter 18. Key Vendor Analysis

18.1. Moderna, Inc.
18.1.1. Company overview
18.1.2. Financial performance
18.1.3. Product Benchmarking
18.1.4. Recent initiatives
18.2. Pfizer Inc.
18.2.1. Company overview
18.2.2. Financial performance
18.2.3. Product Benchmarking
18.2.4. Recent initiatives
18.3. Benchling
18.3.1. Company overview
18.3.2. Financial performance
18.3.3. Product Benchmarking
18.3.4. Recent initiatives
18.4. Orna Therapeutics
18.5. Merck KGaA
18.6. Sanofi
18.7. BioNTech SE
18.8. Daiichi Sankyo Co., Ltd
18.9. GSK PLC
18.10. Sangamo Therapeutics
18.11. AstraZeneca
18.12. Others

Chapter 19. Sourcing Strategy and Downstream Buyers

19.1. MRNA Vaccine and Therapeutics Market Industrial Chain Analysis
19.2. Downstream Buyers

Chapter 20. Marketing Strategy Analysis, Distributors/Traders

20.1. Marketing Channel
20.1.1. Direct Marketing
20.1.2. Indirect Marketing
20.1.3. Marketing Channel Development Trend
20.2. Market Positioning
20.2.1. Pricing Strategy
20.2.2. Brand Strategy
20.2.3. Target Client
20.3. Distributors/Traders List

Chapter 21. Market Effect Factors Analysis

21.1. Product Progress/Risk
21.1.1. Substitutes Threat
21.1.2. Product Progress in Related Size
21.2. Consumer Needs/Customer Preference Change
21.3. Economic/Political Environmental Change

Chapter 22. Future Outlook of the Market

List of Figures

1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global MRNA Vaccine and Therapeutics Market share, By Product, 2023 & 2032 (%)
10. Global MRNA Vaccine and Therapeutics Market share, by Prophylactic Vaccines, By Product, 2018 - 2032 (USD Million)
11. Global MRNA Vaccine and Therapeutics Market share, by Therapeutic Vaccines, By Product, 2018 - 2032 (USD Million)
12. Global MRNA Vaccine and Therapeutics Market share, by Therapeutic Drugs, By Product, 2018 - 2032 (USD Million)
13. Global MRNA Vaccine and Therapeutics Market share, by Others, By Product, 2018 - 2032 (USD Million)
14. Global MRNA Vaccine and Therapeutics Market share, By Disease Type, 2023 & 2032 (%)
15. Global MRNA Vaccine and Therapeutics Market share, by Acute Hepatic Porphyria, By Disease Type, 2018 - 2032 (USD Million)
16. Global MRNA Vaccine and Therapeutics Market share, by Primary Hyperoxaluria Type 1, By Disease Type, 2018 - 2032 (USD Million)
17. Global MRNA Vaccine and Therapeutics Market share, by Hereditary Transthyretin-mediated Amyloidosis Genetic, By Disease Type, 2018 - 2032 (USD Million)
18. Global MRNA Vaccine and Therapeutics Market share, by Atherosclerotic Cardiovascular Disease, By Disease Type, 2018 - 2032 (USD Million)
19. Global MRNA Vaccine and Therapeutics Market share, By Treatment Type, 2023 & 2032 (%)
20. Global MRNA Vaccine and Therapeutics Market share, by Monoclonal Antibody, By Treatment Type, 2018 - 2032 (USD Million)
21. Global MRNA Vaccine and Therapeutics Market share, by Gene Therapy, By Treatment Type, 2018 - 2032 (USD Million)
22. Global MRNA Vaccine and Therapeutics Market share, by Cell Therapy, By Treatment Type, 2018 - 2032 (USD Million)
23. Global MRNA Vaccine and Therapeutics Market share, by Others, By Treatment Type, 2018 - 2032 (USD Million)
24. Global MRNA Vaccine and Therapeutics Market share, By Route of Delivery, 2023 & 2032 (%)
25. Global MRNA Vaccine and Therapeutics Market share, by Intradermal, By Route of Delivery, 2018 - 2032 (USD Million)
26. Global MRNA Vaccine and Therapeutics Market share, by Subcutaneous, By Route of Delivery, 2018 - 2032 (USD Million)
27. Global MRNA Vaccine and Therapeutics Market share, by Intramuscular, By Route of Delivery, 2018 - 2032 (USD Million)
28. Global MRNA Vaccine and Therapeutics Market share, by Intravenous, By Route of Delivery, 2018 - 2032 (USD Million)
29. Global MRNA Vaccine and Therapeutics Market share, by Intranodal, By Route of Delivery, 2018 - 2032 (USD Million)
30. Global MRNA Vaccine and Therapeutics Market share, by Others, By Route of Delivery, 2018 - 2032 (USD Million)
31. Global MRNA Vaccine and Therapeutics Market share, By Application, 2023 & 2032 (%)
32. Global MRNA Vaccine and Therapeutics Market share, by Rare Genetic Diseases, By Application, 2018 - 2032 (USD Million)
33. Global MRNA Vaccine and Therapeutics Market share, by Oncology, By Application, 2018 - 2032 (USD Million)
34. Global MRNA Vaccine and Therapeutics Market share, by Respiratory Diseases, By Application, 2018 - 2032 (USD Million)
35. Global MRNA Vaccine and Therapeutics Market share, by Infectious Diseases, By Application, 2018 - 2032 (USD Million)
36. Global MRNA Vaccine and Therapeutics Market share, by Others, By Application, 2018 - 2032 (USD Million)
37. Global MRNA Vaccine and Therapeutics Market share, By End-use, 2023 & 2032 (%)
38. Global MRNA Vaccine and Therapeutics Market share, by Hospitals & Clinics, By End-use, 2018 - 2032 (USD Million)
39. Global MRNA Vaccine and Therapeutics Market share, by Research Laboratories & Organizations, By End-use, 2018 - 2032 (USD Million)
40. Global MRNA Vaccine and Therapeutics Market share, by Others, By End-use, 2018 - 2032 (USD Million)
41. Global MRNA Vaccine and Therapeutics Market share, by region, 2023 & 2032 (%)
42. Global MRNA Vaccine and Therapeutics Market share, by region, 2018 - 2032 (USD Million)
43. North America MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
44. North America MRNA Vaccine and Therapeutics Market share, by Countries, 2023 & 2032 (%)
45. U.S. MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
46. Canada MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
47. Mexico MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
48. Europe MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
49. Europe MRNA Vaccine and Therapeutics Market share, by Countries, 2023 & 2032 (%)
50. Spain MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
51. UK MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
52. Italy MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
53. Germany MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
54. France MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
55. Rest of Europe MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
56. Asia-Pacific MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
57. Asia-Pacific MRNA Vaccine and Therapeutics Market share, by Countries, 2023 & 2032 (%)
58. China MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
59. India MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
60. Australia MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
61. Japan MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
62. Rest of Asia-Pacific MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
63. Middle East & Africa MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
64. Middle East & Africa MRNA Vaccine and Therapeutics Market share, by Countries, 2023 & 2032 (%)
65. GCC MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
66. South Africa MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
67. Rest of Middle East & Africa MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
68. South America MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
69. Brazil MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
70. Argentina MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
71. Rest of South America MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)

List of Tables

1. Impact of Market drivers
2. Impact of Market restraints
3. Global MRNA Vaccine and Therapeutics Market, 2018 - 2032 (USD Million)
4. Global MRNA Vaccine and Therapeutics Market, by country, 2018 - 2032, (USD Million)
5. North America MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
6. North America MRNA Vaccine and Therapeutics Market, By Disease Type, 2018 - 2032 (USD Million)
7. North America MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
8. North America MRNA Vaccine and Therapeutics Market, By Route of Delivery, 2018 - 2032 (USD Million)
9. North America MRNA Vaccine and Therapeutics Market, By Application, 2018 - 2032 (USD Million)
10. North America MRNA Vaccine and Therapeutics Market, By End-use, 2018 - 2032 (USD Million)
11. Europe MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
12. Europe MRNA Vaccine and Therapeutics Market, By Disease Type, 2018 - 2032 (USD Million)
13. Europe MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
14. Europe MRNA Vaccine and Therapeutics Market, By Route of Delivery, 2018 - 2032 (USD Million)
15. Europe MRNA Vaccine and Therapeutics Market, By Application, 2018 - 2032 (USD Million)
16. Europe MRNA Vaccine and Therapeutics Market, By End-use, 2018 - 2032 (USD Million)
17. Asia Pacific MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
18. Asia Pacific MRNA Vaccine and Therapeutics Market, By Disease Type, 2018 - 2032 (USD Million)
19. Asia Pacific MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
20. Asia Pacific MRNA Vaccine and Therapeutics Market, By Route of Delivery, 2018 - 2032 (USD Million)
21. Asia Pacific MRNA Vaccine and Therapeutics Market, By Application, 2018 - 2032 (USD Million)
22. Asia Pacific MRNA Vaccine and Therapeutics Market, By End-use, 2018 - 2032 (USD Million)
23. Middle East & Africa MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
24. Middle East & Africa MRNA Vaccine and Therapeutics Market, By Disease Type, 2018 - 2032 (USD Million)
25. Middle East & Africa MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
26. Middle East & Africa MRNA Vaccine and Therapeutics Market, By Route of Delivery, 2018 - 2032 (USD Million)
27. Middle East & Africa MRNA Vaccine and Therapeutics Market, By Application, 2018 - 2032 (USD Million)
28. Middle East & Africa MRNA Vaccine and Therapeutics Market, By End-use, 2018 - 2032 (USD Million)
29. South America MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
30. South America MRNA Vaccine and Therapeutics Market, By Disease Type, 2018 - 2032 (USD Million)
31. South America MRNA Vaccine and Therapeutics Market, By Product, 2018 - 2032 (USD Million)
32. South America MRNA Vaccine and Therapeutics Market, By Route of Delivery, 2018 - 2032 (USD Million)
33. South America MRNA Vaccine and Therapeutics Market, By Application, 2018 - 2032 (USD Million)
34. South America MRNA Vaccine and Therapeutics Market, By End-use, 2018 - 2032 (USD Million)
35. Global MRNA Vaccine and Therapeutics Market, Company Market Share, 2022 - 2032 (%)
36. Moderna, Inc.: Product Benchmarking
37. Moderna, Inc.: Financial Performance
38. Pfizer Inc.: Product Benchmarking
39. Pfizer Inc.: Financial Performance
40. Benchling: Product Benchmarking
41. Benchling: Financial Performance
42. Orna Therapeutics: Product Benchmarking
43. Orna Therapeutics: Financial Performance
44. Merck KGaA: Product Benchmarking
45. Merck KGaA: Financial Performance
46. Sanofi: Product Benchmarking
47. Sanofi: Financial Performance
48. BioNTech SE: Product Benchmarking
49. BioNTech SE: Financial Performance
50. Daiichi Sankyo Co., Ltd: Product Benchmarking
51. Daiichi Sankyo Co., Ltd: Financial Performance
52. GSK PLC: Product Benchmarking
53. GSK PLC: Financial Performance
54. Sangamo Therapeutics: Product Benchmarking
55. Sangamo Therapeutics: Financial Performance
56. AstraZeneca: Product Benchmarking
57. AstraZeneca: Financial Performance